Literature DB >> 2622621

Sorsby's fundus dystrophy. A clinical study.

P J Polkinghorne1, M R Capon, T Berninger, A L Lyness, K Sehmi, A C Bird.   

Abstract

A survey was undertaken of a family known to have Sorsby's fundus dystrophy. Fifty members were reviewed, and 14 were found to be affected. Many of Sorsby's original conclusions were confirmed, including the pattern of inheritance and age of visual loss. Yellow material was present at the level of Bruch's membrane early in the course of the disease. However, the earliest phenotypic marker was delayed filling of the choriocapillaris. Abnormalities of choroidal perfusion became more profound and extended centrifugally with time. The loss of central vision was commonly due to atrophy of the outer retina and choroid. Subretinal neovascularization was a rare occurrence. The homology between this dystrophy and age-related macular disease underlines the importance of the clinical findings in this family.

Entities:  

Mesh:

Year:  1989        PMID: 2622621     DOI: 10.1016/s0161-6420(89)32654-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

Review 1.  Bruch's membrane change with age.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

Review 2.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

3.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

Authors:  M A Majid; V A Smith; F J Matthews; A C Newby; A D Dick
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

4.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

5.  Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.

Authors:  Mohammed A Majid; Valerie A Smith; David L Easty; Andrew H Baker; Andrew C Newby
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

6.  A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.

Authors:  U Felbor; H Stöhr; T Amann; U Schönherr; E Apfelstedt-Sylla; B H Weber
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

7.  Sorsby fundus dystrophy without a mutation in the TIMP-3 gene.

Authors:  J J Assink; E de Backer; J B ten Brink; T Kohno; P T de Jong; A A Bergen; F Meire
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

Review 8.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

9.  Linkage refinement localises Sorsby fundus dystrophy between markers D22S275 and D22S278.

Authors:  C Y Gregory; S Wijesuriya; K Evans; M Jay; A C Bird; S S Bhattacharya
Journal:  J Med Genet       Date:  1995-03       Impact factor: 6.318

10.  Late-onset autosomal dominant macular dystrophy with choroidal neovascularization and nonexudative maculopathy associated with mutation in the RDS gene.

Authors:  Shahrokh C Khani; Athanasios J Karoukis; Joyce E Young; Rajesh Ambasudhan; Tracy Burch; Richard Stockton; Richard Alan Lewis; Lori S Sullivan; Stephen P Daiger; Elias Reichel; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.